drug prices news from FiercePharma
News
Roche cuts Tarceva price for U.K.
Need more evidence that the U.K. is playing hardball on drug prices? Here it is: The National Institute for Health and Clinical Excellence agreed to pay for Roche's lung cancer med Tarceva--if and... Read more...
E&Y: Pharma neglects working capital
Could Big Pharma ease some of its ills if it just managed itself better? Ernst & Young says drugmakers could free up to $35 billion in working capital just by improving their management of... Read more...
Specialty drugs getting more costly
We all know specialty meds are expensive, and that they're getting more expensive, too. But now we... Read more...
U.S. drug spending tops the globe
Quick now: Which country's consumers spend the most money on prescription drugs? You got it. U.S. patients shelled out an average of $792 each for their meds in 2005, almost double the overall... Read more...
Cash-poor patients cut back on meds
Pharma stock may be something of a safe haven for investors battered by the yo-yo markets, but as the turmoil continues to leak from Wall Street to Main Street, Read more...
AIDS foundation scolds Abbott
"Shame on Abbott" said the AIDS Healthcare Foundation, which is loudly calling into question the pricing policies of Abbott Laboratories in Mexico. Abbott, the Foundation claims, is picking on... Read more...
UK politicians: Pay for drug performance
The flap over cancer-drug funding is heating up even more in the UK Politicians accused the National Institute of Health and Clinical Excellence (NICE) of spending more money on marketing "spin" than... Read more...
Medicare overpays for new generics
When generics hit the market, the price drops. That's conventional wisdom. But in the case of Medicare, it's not always true. According to a new report from the Health and Human Services inspector... Read more...
Does NICE want pricing power?
Last week, the chief of the U.K.'s National Institute for Health and Clinical Excellence accused drug companies of overpricing their products. Now, sources are telling PharmaTimes that the attack... Read more...
UK won't drop price-fixing cases
A criminal price-fixing trial in the U.K. against several generics makers has fallen apart. But that hasn't stopped the government from trying to collect damages. The National Health Service is... Read more...
Get more drug prices coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
